What Genetic Syndrome Does Angelina Jolie Have and How Did It Affect Her Health Choices?
Learn about Angelina Jolie's BRCA1 gene mutation, its impact on her cancer risk, and her preventive surgeries to reduce health risks.
483 views
Angelina Jolie disclosed in 2013 that she has a mutated BRCA1 gene, which significantly increases her risk of breast cancer and ovarian cancer. This condition led her to make the proactive decision to undergo a preventive double mastectomy and later, a preventive oophorectomy, to dramatically reduce her cancer risk. Her openness about her condition has raised widespread awareness about genetic testing and preventive health measures.
FAQs & Answers
- What is the BRCA1 gene mutation? The BRCA1 gene mutation is a hereditary genetic alteration that significantly increases the risk of breast and ovarian cancers.
- Why did Angelina Jolie choose preventive mastectomy? Angelina Jolie underwent preventive double mastectomy to reduce her substantially elevated risk of breast cancer due to the BRCA1 gene mutation.
- How does genetic testing help in cancer prevention? Genetic testing identifies mutations like BRCA1, enabling individuals to make informed decisions about preventive measures to lower cancer risk.
- What is the difference between breast cancer and ovarian cancer risks with BRCA1 mutation? BRCA1 mutations increase the likelihood of developing both breast and ovarian cancer, prompting some to opt for preventive surgeries targeting these risks.